Finasteride is generally safe for most men, with sexual side effects occurring in roughly 2 to 4% more users than those taking a placebo in clinical trials. It has been on the market since 1992 and is one of the most studied medications for both hair loss and enlarged prostate. But “generally safe” doesn’t mean risk-free, and the specific concerns around this drug deserve a closer look.
How Finasteride Works
Finasteride blocks an enzyme that converts testosterone into a more potent hormone called DHT. DHT is the primary driver of both male pattern hair loss and prostate growth. A daily 1 mg dose reduces DHT levels in the blood by roughly 65 to 70%, which is enough to slow or reverse hair thinning at the scalp and, at the higher 5 mg dose, shrink an enlarged prostate by about 25%.
The drug is approved at 1 mg for male pattern hair loss and at 5 mg for benign prostatic hyperplasia (BPH). Both doses work through the same mechanism, so they share a similar side effect profile, though the higher dose carries somewhat greater risk simply because more of the drug is in your system.
Sexual Side Effects: The Numbers
This is the concern most people search for. In controlled clinical trials of the 1 mg hair loss dose, sexual side effects (erectile difficulty, reduced sex drive, or changes in ejaculation) were reported by about 4.4% of men on finasteride compared to 2.2% on a placebo. That means the drug itself accounts for roughly a 2% increase in risk beyond what men experience from expectation alone.
In real-world clinical practice, the reported rate is even lower, around 0.5% for men taking 1 mg daily. The gap between trial data and clinical data likely reflects the power of suggestion: men in trials are explicitly told about possible sexual side effects before they start, which can influence what they notice and report. Two large pharmaceutical-funded trials found erectile difficulty in 1.4% of finasteride users versus 0.9% on placebo, a small but statistically significant difference.
For most men who do experience these effects, they resolve after stopping the medication. Many also find the side effects diminish over time even while continuing to take it.
Persistent Side Effects After Stopping
A smaller but more troubling question is whether side effects can linger after you quit. Some men report ongoing sexual or psychological symptoms months or even years after discontinuation, a pattern sometimes called “post-finasteride syndrome.” This remains one of the more contested areas in the medical literature.
The UK’s medicines regulator (MHRA) conducted a thorough safety review and concluded there is “mixed evidence” on whether sexual and psychiatric side effects persist after stopping treatment. The agency noted that current product labeling already warns that sexual dysfunction “in some cases continued after treatment was stopped,” and it recommended highlighting this risk more prominently to prescribers and patients. However, the MHRA stopped short of recognizing post-finasteride syndrome as a formal medical diagnosis, noting that doing so falls outside its authority.
What this means practically: persistent effects appear to be rare, but they are not imaginary, and they are acknowledged on the drug’s official labeling. If you notice changes in sexual function or mood that don’t resolve within a few weeks of stopping, that warrants a conversation with your doctor rather than a wait-and-see approach.
Mood and Mental Health
In 2022, the FDA updated finasteride’s prescribing label to include depression and suicidal ideation among postmarketing adverse reactions. These reports come from voluntary submissions rather than controlled trials, so their frequency is hard to pin down, and a direct causal link hasn’t been definitively established. Still, the label change signals that regulators take the signal seriously enough to formalize the warning.
One study on finasteride and depression found that 9.4% of patients reported changes in libido, though it lacked a control group, making the number hard to interpret in isolation. The broader pattern across studies suggests that a small subset of users experience mood changes, and these deserve attention. If you have a history of depression or anxiety, it’s worth weighing this risk before starting treatment.
Prostate Cancer: A Complicated Story
The Prostate Cancer Prevention Trial, a landmark NCI-funded study of nearly 19,000 men, found that daily finasteride for seven years substantially reduced the overall risk of developing prostate cancer. That sounds like a clear win, but the same trial raised an alarming possibility: finasteride might increase the risk of high-grade, more aggressive prostate cancers.
Follow-up analyses offered a reassuring explanation. Finasteride shrinks the prostate by about 25%, which means a standard biopsy needle is more likely to hit a cancerous area in a smaller gland. The drug also makes the PSA blood test more sensitive at detecting aggressive cancers. In other words, finasteride likely didn’t cause more high-grade cancers. It just made them easier to find. Researchers at the National Cancer Institute concluded that the trial probably overestimated the harm and underestimated the benefit of finasteride for prostate cancer prevention.
Effects on PSA Screening
If you take finasteride and get routine PSA tests for prostate cancer screening, you need to know that the drug typically cuts your PSA level in half within 9 to 12 months. It stays at that reduced level for as long as you take the medication. This means your doctor needs to double your measured PSA value to get an accurate reading. If your healthcare provider doesn’t know you’re on finasteride, a dangerously high PSA could look normal on paper. Always mention finasteride use before any prostate screening.
Safety for Women and During Pregnancy
Finasteride is approved for use in men only. Because it interferes with a hormone pathway critical to the development of male genitalia, there was longstanding concern about pregnant women being exposed through their partner’s semen. The NHS notes that only very small amounts of the drug are present in semen, and most experts agree the actual risk to a pregnancy is not significant. The manufacturer’s labeling still suggests using a condom as a precaution, but this recommendation is widely considered overly cautious by clinicians.
Women who are or could become pregnant should not handle crushed or broken finasteride tablets, since the drug can be absorbed through the skin. Intact tablets are coated and safe to touch.
Putting the Risk in Perspective
Finasteride’s safety profile is well established over three decades of use. The most common side effects are sexual in nature, affect a small percentage of users, and typically reverse when the drug is stopped. The more serious concerns, persistent sexual dysfunction and mood changes, are rare but real, and regulatory agencies worldwide have updated labeling to reflect them.
Your individual risk depends on factors like your baseline mental health, your sensitivity to hormonal changes, and whether you’re taking the 1 mg or 5 mg dose. For the majority of men, finasteride is a low-risk medication with a strong track record. For the small minority who experience side effects, the key is recognizing them early and knowing that stopping the drug is a straightforward option.